Table of Contents

Biotechnology and Innovation Systems

Biotechnology and Innovation Systems

The Role of Public Policy

Edited by Bo Göransson and Carl Magnus Pålsson

This book explores how policies targeting public research institutions, such as universities, contribute to the appropriation of biotechnology through national innovation systems.

Chapter 13: Biotechnology: National Policy and Development Priorities in Russia

Galina Sagieva

Subjects: environment, biotechnology, innovation and technology, biotechnology, innovation policy, politics and public policy, public policy


Galina Sagieva INTRODUCTION Biotechnology belongs to the group of breakthrough, rapidly-developing technologies. It allows society to deal with major socio-economic challenges such as increasing crop productivity; production of bioactive substances, vaccines; biosynthesis of antibiotics, hormones, interferon; early diagnostics and treatment of various diseases, and so on. Many experts believe that only bioprocesses have the potential to provide radical, global solutions to such challenges as production of food and environment protection. The development of biotechnologies is expected to create opportunities to greatly increase food reserves; develop new sustainable energy sources; prevent and efficiently treat severe diseases; further develop waste-free production technologies; and reduce adverse impact on the environment. In Russia, biotechnology is seen as a major priority of S&T development; in policy statements it is designated ‘live systems’, and as such enjoys active government support through various targeted federal programmes. However, the country still lacks a system of statistical monitoring in the biotech sphere (data on internal R&D expenditures in this priority area has been collected since 2008 – but it is clearly not enough to measure overall activities in the biotechnology field). The statistical classification of products and economic activities (OKPD) does not have designated classes and groups for biotech products. Modern biotechnologies based on advanced R&D results have high potential and are becoming increasingly more efficient, which strengthens and diversifies their effect not just on the human environment but directly on the human organism and its components, including genetic structures. Creation of genetic databases, introduction of passports...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information